Nội dung được dịch bởi AI, chỉ mang tính chất tham khảo
Liệu pháp gen cải thiện chức năng miễn dịch ở trẻ vị thành niên mắc bệnh thiếu máu miễn dịch kết hợp nặng do liên kết với nhiễm sắc thể X
Tóm tắt
Từ khóa
#Liệu pháp gen #thiếu máu miễn dịch kết hợp nặng do liên kết với nhiễm sắc thể X #tế bào T #retrovirus #tự thân #tế bào gốc huyết họcTài liệu tham khảo
Cavazzana-Calvo, 2000, Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease., Science, 288, 669, 10.1126/science.288.5466.669
Hacein-Bey-Abina, 2003, LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1., Science, 302, 415, 10.1126/science.1088547
Gaspar, 2004, Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector., Lancet, 364, 2181, 10.1016/S0140-6736(04)17590-9
Puck, 2007, X-linked severe combined immunodeficiency., Primary Immunodeficiency Diseases, a Molecular and Genetic Approach, 2nd ed., 123
Buckley, 1999, Hematopoietic stem cell transplantation for the treatment of severe combined immunodeficiency., New Engl J Med, 340, 508, 10.1056/NEJM199902183400703
Haddad, 1998, Long term immune reconstitution and outcome after HLA-nonidentical T-cell depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients., Blood, 91, 3646
Antoine, 2003, Long-term survival and transplantation of hematopoietic stem cells for immunodeficiencies: report of the European experience 1968-1999., Lancet, 361, 553, 10.1016/S0140-6736(03)12513-5
Myers, 2002, Hematopoietic stem cell transplantation for SCID in the neonatal period leads to superior thymic output and improved survival., Blood, 99, 872, 10.1182/blood.V99.3.872
Buckley, 2007, Bone marrow transplantation for primary immunodeficiency diseases., Primary Immunodeficiency Diseases, a Molecular and Genetic Approach, 2nd ed., 669
Smogorzewska, 2000, T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency., Arch Immunol Ther Exp (Warsz), 48, 111
Haddad, 1999, Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: a single center study of 22 patients., Blood, 94, 2923, 10.1182/blood.V94.8.2923.420k44_2923_2930
Cole, 2000, Dental manifestations in severe combined immunodeficiency following bone marrow transplantation., Bone Marrow Transplant, 25, 1007, 10.1038/sj.bmt.1702382
Slatter, 2004, Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning., Bone Marrow Transplant, 33, 949, 10.1038/sj.bmt.1704456
Clement, 1996, Final height and hormonal function after bone marrow transplantation in children., J Pediatr, 129, 544, 10.1016/S0022-3476(96)70119-1
Cavazzana-Calvo, 2005, Gene therapy for severe combined immunodeficiency., Annu Rev Med, 56, 585, 10.1146/annurev.med.56.090203.104142
Gray, 2006, The effect of the B2 mutation on hematopoietic reconstitution in the French XSCID gen therapy trial., Mol Ther, 13, S254, 10.1016/j.ymthe.2006.08.737
Tsai, 2002, Retroviral transduction of IL2RG into CD34(+) cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras., Blood, 100, 72, 10.1182/blood.V100.1.72
Roesler, 2002, Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease., Blood, 100, 4381, 10.1182/blood-2001-12-0165
Horwitz, 2001, Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft., N Engl J Med, 344, 881, 10.1056/NEJM200103223441203
Lyons, 2000, Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution., J Immunol Methods, 243, 147, 10.1016/S0022-1759(00)00231-3
Douek, 1998, Changes in thymic function with age and during the treatment of HIV infection., Nature, 396, 690, 10.1038/25374
Sarzotti, 2003, T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation., J Immunol, 170, 2711, 10.4049/jimmunol.170.5.2711
Schmidt, 2001, A model for the detection of clonality in marked hematopoietic stem cells., Ann N Y Acad Sci, 938, 146, 10.1111/j.1749-6632.2001.tb03584.x
Schmidt, 2002, Polyclonal long-term repopulating stem cell clones in a primate model., Blood, 100, 2737, 10.1182/blood-2002-02-0407
Wu, 2003, Transcription start regions in the human genome are favored targets for MLV integration., Science, 300, 1749, 10.1126/science.1083413
Puck, 1997, Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency., Blood, 89, 1968
Malech, 1997, Prolonged production of NADPH oxidase-corrected granulocytes following gene therapy of chronic granulomatous disease., Proc Natl Acad Sci U S A, 94, 12133, 10.1073/pnas.94.22.12133
Malech, 2000, Use of serum-free medium with fibronectin fragment enhanced transduction in a system of gas permeable plastic containers to achieve high levels of retrovirus transduction at clinical scale., Stem Cells, 18, 155, 10.1634/stemcells.18-2-155
Malech, 2004, Progress toward effective gene therapy for chronic granulomatous disease., Jpn J Inf Dis, 57, S27
Schmidt, 2005, Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial., Blood, 105, 2699, 10.1182/blood-2004-07-2648
Wu, 2006, Redefining the common integration site., Virology, 344, 292, 10.1016/j.virol.2005.08.047
Thrasher, 2005, Failure of SCID-X1 gene therapy in older patients., Blood, 105, 4255, 10.1182/blood-2004-12-4837